Accent Capital Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.8K Buy
+201
New +$8.43K 0.01% 202
2025
Q3
Sell
-200
Closed -$5.41K 433
2025
Q2
$5.41K Sell
200
-242
-55% -$7.01K ﹤0.01% 323
2025
Q1
$13.1K Hold
442
0.01% 182
2024
Q4
$17.5K Hold
442
0.01% 119
2024
Q3
$15K Buy
+442
New +$12.4K 0.01% 150

Other funds holding VCYT

Accent Capital Management's VCYT Position: Q2 2026 in Review

Accent Capital Management opened a new position in Veracyte (VCYT) in Q2 2026: 201 shares worth $11.8K. The stake represents 0.01% of the portfolio and ranks #202 among its holdings. This is a return to the name: Accent Capital Management previously reported a position in VCYT as recently as Q2 2025.

Accent Capital Management first reported a position in VCYT in Q3 2024 and has held it in 5 quarters since. The position peaked at $17.5K in Q4 2024. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Accent Capital Management held 201 shares of Veracyte worth $11.8K as of Q2 2026.
  • Veracyte was a new Accent Capital Management position in Q2 2026.
  • Veracyte made up 0.01% of Accent Capital Management's portfolio in Q2 2026, its #202 holding.
  • Accent Capital Management first reported a position in Veracyte in Q3 2024 and has held it in 5 quarters since.
  • Accent Capital Management's Veracyte position peaked at $17.5K in Q4 2024.
  • 371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Accent Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.